Krystal Biotech Inc. (KRYS)
NASDAQ · Healthcare
Krystal Biotech Inc. Revenue 2020–2025
Krystal Biotech Inc. annual/quarterly revenue history and growth rate from 2020 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Krystal Biotech Inc. revenue for the quarter ending March 31, 2026 was 116.4 M, a 31.95% increase year-over-year.
- Krystal Biotech Inc. revenue for the twelve months ending March 31, 2026 was 417.3 M.
- Krystal Biotech Inc. annual revenue for 2025 was 389.1 M, a 33.94% increase from 2024.
- Krystal Biotech Inc. annual revenue for 2024 was 290.5 M, a 473.02% increase from 2023.
- Krystal Biotech Inc. annual revenue for 2023 was 50.7 M.
- Krystal Biotech Inc. annual revenue for 2022 was 0.
Revenue
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Krystal Biotech Inc. Earnings — FAQ
Krystal Biotech Inc. (KRYS) earnings over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see KRYS's earnings history?
The chart and table above show Krystal Biotech Inc.'s earnings by year and by quarter, including the growth rate.